Moreover, an increased PRA/PRB ratio in breast cancer cells has been shown to induce changes in cell morphology and the loss of cell adhesion in response to progesterone receptor agonists, along with a membrane-to-cytoplasm redistribution of the ERM protein, ezrin [45]. The gene discussed is EZR; the disease is breast carcinoma.